DarioHealth reports Q2 EPS 18c, consensus (10c)

Reports Q2 revenue $5.37M, consensus $6.91M. “Our 2025 second quarter topline results fell short of our internal goals,” said Erez Raphael, CEO of Dario. “However, the underlying momentum in client signings, the strategic quality of new contracts, and growing channel strength give us confidence that the temporary revenue dip will be offset by accelerated growth going forward. We remain focused on signing and onboarding new B2B2C clients, yielding high-quality, sustainable annual recurring revenue growth. Despite these short-term headwinds, I believe that we will continue to show strength in strategic execution as two new health plan clients are expected to represent multi-million-dollar opportunities for Dario over time, including a full-suite national health plan scheduled to launch in the second half of 2025.”